This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.11, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This award is not designated under any set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,780.50, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,629.90, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,218.16, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of October 22, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,664.34, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,667.40, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of February 20, 2025. The contract is not associated with a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,947.90, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of November 22, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.68, is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,408.02, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of March 28, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order valued at $7,351.20, with a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...